A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression.

Trial Profile

A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2009

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 28 Sep 2008 Planned end date changed from 1 Jul 2008 to 1 Mar 2008 as reported by CT.gov
    • 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov
    • 24 Aug 2008 Actual patient number (392) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top